| Ident. | Authors (with country if any) | Title |
|---|
| 003D24 |
Lene Mellemkjaer [Danemark] ; S Ren Friis [Danemark] ; J Rgen H. Olsen [Danemark] ; Ghislaine Scelo [France] ; Kari Hemminki [Allemagne, Suède] ; Elizabeth Tracey [Australie] ; Aage Andersen [Norvège] ; David H. Brewster [Royaume-Uni] ; Eero Pukkala [Finlande] ; Mary L. Mcbride [Canada] ; Erich V. Kliewer [Canada] ; Jon M. Tonita [Canada] ; Chia Kee-Seng [Singapour] ; Vera Pompe-Kirn [Slovénie] ; Carmen Martos [Espagne] ; Jon G. Jonasson [Islande] ; Paolo Boffetta [France] ; Paul Brennan [France] | Risk of second cancer among women with breast cancer |
| 003D61 |
Florent Cachin [Australie, France] ; H. Miles Prince ; Annette Hogg ; Robert E. Ware ; Rodney J. Hicks | Powerful prognostic stratification by [18F] fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy |
| 004293 |
Jocelyne Jacquemier [France] ; Laetitia Padovani [France] ; Laetitia Rabayrol [France] ; Sunil R. Lakhani [Royaume-Uni, Australie] ; Frédérique Penault-Llorca [France] ; Yves Denoux [France] ; Maryse Fiche [France] ; Paulo Figueiro [Portugal] ; Véronique Maisongrosse [France] ; Viviane Ledoussal [France] ; Jose Martinez Penuela [Espagne] ; Nora Udvarhely [Hongrie] ; George El Makdissi [France] ; Christophe Ginestier [France] ; Jeannine Geneix [France] ; Emmanuelle Charafe-Jauffret [France] ; Luc Xerri [France] ; Francois Eisinger [France] ; Daniel Birnbaum [France] | Typical medullary breast carcinomas have a basal/myoepithelial phenotype |
| 004395 |
K. Hemminki [Allemagne, Suède] ; G. Scelo [France] ; P. Boffetta [France] ; L. Mellemkjaer [Danemark] ; E. Tracey [Australie] ; A. Andersen [Norvège] ; D. H. Brewster [Royaume-Uni] ; E. Pukkala [Finlande] ; M. Mcbride [Canada] ; E. V. Kliewer [Canada] ; K.-S. Chia [Singapour] ; V. Pompe-Kirn [Slovénie] ; C. Martos [Espagne] ; J. G. Jonasson [Islande] ; X. Li [Suède] ; P. Brennan [France] | Second primary malignancies in patients with male breast cancer |
| 004422 |
Michel Marty [France, Italie, Australie, Royaume-Uni, Espagne, Irlande (pays), Suisse] ; Francesco Cognetti ; Dominique Maraninchi ; Ray Snyder ; Louis Mauriac ; Michèle Tubiana-Hulin ; Stephen Chan ; David Grimes ; Antonio Anton ; Ana Lluch ; John Kennedy ; Kenneth O'Byrne ; Pier Franco Conte ; Michael Green ; Carol Ward ; Karen Mayne ; Jean-Marc Extra | Randomized phase ii trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment : The M77001 study group |
